Skip Navigation LinksHome > May 2013 - Volume 32 - Issue 5 > New Aspects on Human Rhinovirus Infections
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e3182833c90
Reports and Reviews from the European Society for Paediatric Infectious Diseases

New Aspects on Human Rhinovirus Infections

Ruuskanen, Olli MD, PhD*; Waris, Matti PhD; Ramilo, Octavio MD

Free Access
Article Outline
Collapse Box

Author Information

From the *Department of Pediatrics, Division of Infectious Diseases, Turku University Hospital; Department of Virology, University of Turku, Turku, Finland; and Division of Infectious Diseases, Nationwide Children’s Hospital and Ohio State University, Columbus, OH.

The authors have no funding or conflicts of interest to disclose.

Address for correspondence: Olli Ruuskanen, MD, PhD, Department of Pediatrics, Turku, University Hospital, 20520 Turku, Finland. E-mail: olli.ruuskanen@tyks.fi.

Many large studies performed in 1960s detected human rhinovirus (HRV) by virus isolation in one quarter of the cases with acute upper respiratory infections, and HRV was mainly considered a common cold virus. Virus culture, the standard method for detection, was carried out in research laboratories with special expertise and the role of HRV outside common cold remained unclear. During 1990s, polymerase chain reaction (PCR) techniques for HRV became generally available and they revolutionized HRV studies bringing important new biologic and clinical observations.1–3

Back to Top | Article Outline

Virology

HRVs are positive-strand RNA viruses of the genus Enterovirus in the family Picornaviridae. In addition to HRV, enterovirus, parechovirus and hepatovirus in the picornavirus family cause human infections. With virus culture techniques 100 HRV serotypes have been identified. Genome sequencing revealed originally 2 species, A and B. Recent studies of strains, which were uncultivable but detectable by PCR, resulted in classification of new species C with a current number of 60 genotypes. They also show that recombinatorial events have taken place during the evolution of HRVs. HRV-C viruses do not use intercellular adhesion molecule-1 (major) or the low-density lipoprotein receptor (minor) as receptors as do HRV-A and HRV-B species.2,4–7

Back to Top | Article Outline

Clinical Profile on Natural Rhinovirus Infections

HRV is undoubtly the most commonly detected respiratory virus in all age groups and probably the most common causative agent of all acute infections in humans. By 2 years of age, >90% of the children have experienced at least 1 HRV infection.8 HRVs are associated with 5 hospitalizations per 1000 children <5 years old in the United States.9 HRV infection is associated with a wide range of clinical presentations including classic common cold, acute otitis media (AOM), sinusitis, severe bronchiolitis, asthma, pneumonia, fever alone, infections in preterm infants, severe infections in immunosuppressed patients, as well as worsening of chronic conditions particularly asthma, cystic fibrosis and chronic obstructive pulmonary disease. It is becoming well established that HRV-A and HRV-C are more common and may cause more severe illnesses in infants than HRV-B.7 PCR studies also suggest that subclinical infections may be much more common than earlier understood. Subclinical infections have also been recorded many years ago in experimental HRV studies, in which virus culture was used.10

Back to Top | Article Outline

Common Cold

Compared with other respiratory viruses, HRVs have a dominant role as causative agents of upper respiratory tract infections both in young children, adults and elderly people. HRVs were detected in 52% of 200 young adults with common cold and in 92% during September and October.11 In 194 young children with newly onset common cold at least 1 respiratory virus was detected in 92% of the patients. HRV was the most common respiratory virus, found in 71% of the children.12

Back to Top | Article Outline

Acute Otitis Media

Respiratory syncytial virus (RSV) has earlier been considered a major predisposing factor to development of AOM. Studies with HRV PCR suggest a dominant role of also HRVs.13 In the Finnish Otitis Media Cohort Study, 759 AOM events were recorded and 42% of these events were associated with HRV infections. In the second part of this study, HRV was detected in 32% of 1416 AOM events. Rhinovirus RNA has been detected in 17%–41% of the middle ear fluid specimens from children with AOM.14

Back to Top | Article Outline

Bronchiolitis, Recurrent Wheezing and Asthma

HRV is associated in up to one quarter of bronchiolitis cases in infants. In a 3-year prospective study, Calvo and colleagues15 investigated the frequency of 16 respiratory viruses in 318 children (mean age 6 months) hospitalized with bronchiolitis. A virus was found in 87% of the cases, RSV in 61% and HRV in 17%. In a prospective multicenter 3-year study in the United States, Mansbach and colleagues examined 2207 children younger than 2 years hospitalized for severe bronchiolitis. A virus was detected in 94% of the cases, RSV in 72% and HRV in 26%, and other viruses in 7%.16 RSV dominates in infants and HRV in children older than 12 months.17 Interestingly, HRV-infected children had a significantly shorter hospital length of stay as compared with children with RSV bronchiolitis.16 Fatal HRV bronchiolitis was recently reported in Vietnam.18 Innate immune responses inversely correlate with the HRV disease severity.19

Several studies have shown that infants with bronchiolitis will have significantly more often recurrent wheezing than controls without bronchiolitis. HRV as the causative agent is the most important risk factor, followed by a positive family history for asthma or atopy.20–22 Severe episodes of bronchiolitis increases the odds of early asthma.23 In a long-term postbronchiolitis follow-up in Finland, asthma at 7 years of age was more common after HRV (52%) than after RSV (15%) bronchiolitis.20 At the moment it is not understood whether HRV infection causes asthma or whether it only identifies the susceptible children and promotes the development. There is evidence that early prednisolone treatment of HRV-induced wheezing may reduce recurrent wheezing. This requires further confirmation, as prednisolone treatment does not achieve a similar benefit in bronchiolitis caused by RSV.24

Up to 90% of asthma exacerbations in children are associated with virologically defined natural respiratory virus infections. HRV is the most commonly found virus and is detected approximately in two thirds of the cases. Children with asthma and allergic sensitization are more prone to HRV infections. There is evidence that asthmatic patients have more frequent HRV, more severe, and longer lasting lower respiratory tract infections than nonasthmatics.25

Many studies have unveiled the mechanisms of increased susceptibility to HRV infections in asthmatic patients. They include changes in airway epithelium, defective HRV-induced secretion of interferon-β, interferon-λ, interleukin-10 and probably interferon-α, and impaired alveolar macrophage function.20,25

Back to Top | Article Outline

Pneumonia

HRV has been indentified from induced sputum, tracheal brushing, bronchoalveolar lavage samples and lung tissue samples strongly suggesting that HRV can induce lower respiratory tract infections. Nine studies on childhood community-acquired pneumonia (CAP) (N = 4279 episodes) using PCR methods for virus detection found HRV in 18% of the cases.26 In 1 new study in Italy, 592 children with CAP were included and HRV was identified in 172 cases (29%).27 The clinical profile of 643 HRV infections in children admitted to hospital were reported in 7 studies and 11%–53% had pneumonia.26,28 HRVs are commonly detected in children with severe pneumonia also in developing countries.29,30 These new findings suggest that HRVs are important causative agents of pneumonia both in children and in adults and in immunosuppressed subjects.

Back to Top | Article Outline

HRV RNA in Asymptomatic Individuals

The clinical importance of detection HRV RNA by RT-PCR can be questioned. HRV RNA can be detected before, during and after symptomatic infection, in subclinical infection, or it may just be an innocent contamination. Several studies have indentified HRV RNA in 12%–35% of asymptomatic subjects.10 In 1 recent study, HRV was detected in the nasopharynx of 433 6- to 24-month-old healthy children from 31% to 50% of samples.31 It is important to recognize that in otherwise healthy subjects, HRV is not known to induce chronic illness and virus shedding lasts 2–4 weeks after acute HRV infection. For these reasons, Jartti and coworkers10 concluded that PCR-positive respiratory HRV finding detects most probably true infection with or without symptoms.

Back to Top | Article Outline

Coinfections With Other Viruses and Bacteria

In 4 recent studies, HRV was detected in association with one or more other respiratory viruses in 24%, 34%, 37% and 70% of the cases.12,15,16,30 The clinical relevance of detection of several viruses is uncertain and it certainly can be asked what is the role of HRV when it is detected by PCR with 3 other viruses.

Interest has grown with respect to the interaction of bacteria and viruses in the pathogenesis of respiratory infections. Earlier, in contrast to for example influenza viruses, HRVs have not been considered to facilitate bacterial coinfections. Ruohola and coworkers studied etiology of AOM in 79 middle ear fluids suctioned through tympanostomy tube. In 16 cases HRV was detected, and in all cases they were detected together with pathogenic bacteria.13 Honkinen and colleagues28 studied induced sputum of 76 children with CAP and found HRV plus Streptococcus pneumoniae in 12 of 23 HRV cases. Similarly, in adults with CAP the most frequent viral–bacterial combination has been HRV plus S. pneumoniae.32 Peltola and coworkers33 found a temporal association between HRV infection and invasive pneumococcal disease in children.

Experimental HRV infection in patients with chronic obstructive pulmonary disease was followed by secondary bacterial infection in 60% of the subjects. Bacterial infections were associated with reduced levels of antimicrobial peptides.34 In healthy children, S. pneumoniae was positively associated with HRV in the nasopharynx.31 New observations in mice suggest that HRV may increase the risk of secondary bacterial infection by attenuating TLR-dependent immune responses.35

Back to Top | Article Outline

Diagnosis

Today RT-PCR is the method of choice for the detection of HRV because it is easier to perform, more sensitive than HRV culture and detects HRV-C. However, it should be emphasized, that a positive PCR test result does not necessarily reflect active virus replication, as does positive virus culture. A difficulty with HRV is the paucity of serologic tests to verify acute infection.

Including HRV into multiplex PCR assays has increased the number of diagnoses. The most sensitive PCRs for HRVs amplify parts of the 5′ noncoding region. They are not always selective for HRVs but also detect human enteroviruses. The differentiation requires additional confirmation like sequencing, although melting temperature determination can be used as a screening tool.36 Flocked swabs with nylon fibres are now preferred for nasal or nasopharyngeal sampling because they are convenient to use and have similar or better sensitivity than nasopharyngeal aspirates or nasopharyngeal washes.36–38 Self sampling conducted at home by the parents with subsequent shipping of the samples by mail to the laboratory has been successfully used in clinical studies.36

The clinical significance of HRV load is not well established. Jansen and coworkers39 detected higher HRV loads in children with acute symptomatic respiratory infections compared with asymptomatic controls. Utokaparch and associates40 detected significantly higher HRV load in lower respiratory tract infections versus nonlower respiratory tract infections. On the other hand, no correlation between HRV load and the disease severity was reported by Takeyama et al.41

Back to Top | Article Outline

Treatment and Prevention

No antiviral drug has been approved for clinical use in HRV infections. All possible candidates have turned out to be disappointments. Oral capsid-binding HRV inhibitor, vapendavir and inhaled interferon-β are being studied.42 New HRV murine models may facilitate the development of new agents.43

The antigenic diversity of HRV makes development of effective vaccines difficult. At the moment, the only way to reduce HRV disease burden is prevention of transmission. In a family setting, the rates of HRV infections were 1.00 cases per person among siblings and 0.50 cases per person among parents of HRV-positive index patients.36 Studies carried out 15–25 years ago showed that a major route of transmission is probably from hands of infected subjects to an intermediary surface or directly to the fingers of the susceptible recipient. HRV may remain infectious for at least several hours on different surfaces like doorknobs, refrigerator door handles and television remote controls.44 Infection is then transmitted by self-inoculation of the nose or eye. Importantly, this chain may be effectively interrupted by the old technique—washing hands with water and soap, which removes HRV efficiently.45 However, hand disinfection with 2% citric acid and 2% malic acid in 62% ethanol does not reduce HRV infection or HRV-related common cold illnesses.46

Back to Top | Article Outline

ACKNOWLEDGMENT

We thank our friend professor Frederick G. Hayden for valuable comments on the article.

Back to Top | Article Outline

REFERENCES

1. Mackay IM. Human rhinoviruses: the cold wars resume. J Clin Virol. 2008;42:297–320

2. Arden KE, Mackay IM. Newly identified human rhinoviruses: molecular methods heat up the cold viruses. Rev Med Virol. 2010;20:156–176

3. Jacobs SE, Lamson DM, St George K, et al. Human rhinoviruses. Clin Microbiol Rev. 2013;26:135–162

4. Simmonds P, McIntyre C, Savolainen-Kopra C, et al. Proposals for the classification of human rhinovirus species C into genotypically assigned types. J Gen Virol. 2010;91(Pt 10):2409–2419

5. Bochkov YA, Gern JE. Clinical and molecular features of human rhinovirus C. Microbes Infect. 2012;14:485–494

6. Mackay IM, Lambert SB, Faux CE, et al. Community-wide, contemporaneous circulation of a broad spectrum of human rhinoviruses in healthy Australian preschool-aged children during a 12-month period. J Infect Dis. [published online ahead of print September 6, 2012]. doi: 10.1093/infdis/jis476.

7. Lee WM, Lemanske RF Jr, Evans MD, et al. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med. 2012;186:886–891

8. Blomqvist S, Roivainen M, Puhakka T, et al. Virological and serological analysis of rhinovirus infections during the first two years of life in a cohort of children. J Med Virol. 2002;66:263–268

9. Miller EK, Lu X, Erdman DD, et al.New Vaccine Surveillance Network. Rhinovirus-associated hospitalizations in young children. J Infect Dis. 2007;195:773–781

10. Jartti T, Jartti L, Peltola V, et al. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J. 2008;27:1103–1107

11. Mäkelä MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36:539–542

12. Ruohola A, Waris M, Allander T, et al. Viral etiology of common cold in children, Finland. Emerging Infect Dis. 2009;15:344–346

13. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43:1417–1422

14. Nokso-Koivisto J, Räty R, Blomqvist S, et al. Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J Med Virol. 2004;72:241–248

15. Calvo C, Pozo F, García-García ML, et al. Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr. 2010;99:883–887

16. Mansbach JM, Piedra PA, Teach SJ, et al.MARC-30 Investigators. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012;166:700–706

17. Jartti T, Lehtinen P, Vuorinen T, et al. Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J. 2009;28:311–317

18. Hai LT, Bich TN, Ngai LK, et al. Fatal respiratory infections associated with rhinovirus outbreaks, Vietnam. Emerg Infect Dis. 2012;18:1886–1888

19. García C, Soriano-Fallas A, Lozano J, et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J. 2012;31:86–89

20. Jartti T, Korppi M. Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol. 2011;22:350–355

21. Kim WK, Gern JE. Updates in the relationship between human rhinovirus and asthma. Allergy Asthma Immunol Res. 2012;4:116–121

22. Midulla F, Pierangeli A, Cangiano G, et al. Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up. Eur Respir J. 2012;39:396–402

23. James KM, Peebles RS Jr, Hartert TV. Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol. 2012;130:343–351

24. Lehtinen P, Ruohola A, Vanto T, et al. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol. 2007;119:570–575

25. Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125:1178–1187; quiz 1188

26. Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia. Lancet. 2011;377:1264–1275

27. Esposito S, Daleno C, Tagliabue C, et al. Impact of rhinoviruses on pediatric community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 2012;31:1637–1645

28. Honkinen M, Lahti E, Österback R, et al. Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect. 2012;18:300–307

29. Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008;27:939–941

30. Suzuki A, Lupisan S, Furuse Y, et al. Respiratory viruses from hospitalized children with severe pneumonia in the Philippines. BMC Infect Dis. 2012;12:267

31. van den Bergh MR, Biesbroek G, Rossen JW, et al. Associations between Pathogens in the Upper Respiratory Tract of Young Children: Interplay between Viruses and Bacteria. PLoS ONE. 2012;7:e47711

32. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63:42–48

33. Peltola V, Heikkinen T, Ruuskanen O, et al. Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J. 2011;30:456–461

34. Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:1117–1124

35. Unger BL, Faris AN, Ganesan S, et al. Rhinovirus attenuates non-typeable Hemophilus influenzae-stimulated IL-8 responses via TLR2-dependent degradation of IRAK-1. PLoS Pathog. 2012;8:e1002969

36. Peltola V, Waris M, Osterback R, et al. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis. 2008;197:382–389

37. Heikkinen T, Marttila J, Salmi AA, et al. Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol. 2002;40:4337–4339

38. Debyle C, Bulkow L, Miernyk K, et al. Comparison of nasopharyngeal flocked swabs and nasopharyngeal wash collection methods for respiratory virus detection in hospitalized children using real-time polymerase chain reaction. J Virol Methods. 2012;185:89–93

39. Jansen RR, Wieringa J, Koekkoek SM, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol. 2011;49:2631–2636

40. Utokaparch S, Marchant D, Gosselink JV, et al. The relationship between respiratory viral loads and diagnosis in children presenting to a pediatric hospital emergency department. Pediatr Infect Dis J. 2011;30:e18–e23

41. Takeyama A, Hashimoto K, Sato M, et al. Rhinovirus load and disease severity in children with lower respiratory tract infections. J Med Virol. 2012;84:1135–1142

42. Hayden FG, Turner RB. Rhinovirus genetics and virulence: looking for needles in a haystack. Am J Respir Crit Care Med. 2012;186:818–820

43. Bartlett NW, Walton RP, Edwards MR, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med. 2008;14:199–204

44. Winther B, McCue K, Ashe K, et al. Rhinovirus contamination of surfaces in homes of adults with natural colds: transfer of virus to fingertips during normal daily activities. J Med Virol. 2011;83:906–909

45. Savolainen-Kopra C, Korpela T, Simonen-Tikka ML, et al. Single treatment with ethanol hand rub is ineffective against human rhinovirus–hand washing with soap and water removes the virus efficiently. J Med Virol. 2012;84:543–547

46. Turner RB, Fuls JL, Rodgers ND, et al. A randomized trial of the efficacy of hand disinfection for prevention of rhinovirus infection. Clin Infect Dis. 2012;54:1422–1426

rhinovirus; common cold; pneumonia

© 2013 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.